百心安(02185.HK)開展RADIUS-HTN臨床試驗

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

百心安(02185.HK)開展RADIUS-HTN臨床試驗

阿思達克 05-20 02:32

百心安－Ｂ(02185.HK)公布，歐洲心血管研究中心(CERC)將進行RADIUS-HTN(腎動脈去交感神經治療未控高血壓)試驗，並評估公司的第二代Iberis腎神經阻斷(RDN)系統治療未控高血壓患者。第二代Iberis由公司與戰略業務合作者泰爾茂合作開展，是一種通過裝置進行用於治療高血壓的低侵入性手術。

百心安-B(02185.HK)

Relevant Stocks

百心安-B(02185.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

百心安(02185.HK)開展RADIUS-HTN臨床試驗

Services

About Us

Agreement Statement